Interest in oligonucleotide therapeutics has grown, as has the market demand, since their emergence as a new drug modality two decades ago.

Interview with Karl Rotthier, CEO of the Sanofi spin-off EuroAPI.

Italian API producer Olon has announced plans to install a new high-containment production line at its site in Mahad, India.

Financed in part by the French government’s France Relance plan, Novasep‐PharmaZell is investing €7.3 million in production of active pharmaceuticals (APIs) at its...

WuXi AppTec and its subsidiary Wuxi STA have announced several investments in manufacturing and research in Asia, with the Changzou campus in China’s Jiangsu Province a...

South Korean CDMO SK Pharmteco (SKTP) said it will spend $35 million on the initial phase of a planned expansion at the Dublin, Ireland, API site the conglomerate...

Major API supplier Olon is establishing a €10 million central R&D hub at its headquarters site in Roadano, near Milan. The Italian company said the facility paves the way...

The value in applying AI in Pharma is in making new and better drugs available faster than would be possible otherwise. By augmenting sparse-data AI with expert knowledge...